Sofinnova Partners

@SofinnovaParis

For more than 45 years, the firm has backed nearly 500 companies at different stages of their development.

Paris
Vrijeme pridruživanja: veljača 2012.

Tweetovi

Blokirali ste korisnika/cu @SofinnovaParis

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SofinnovaParis

  1. 23. sij

    How do you spot a winner? Our managing partner Antoine Papiernik gives insight into his process in this member exclusive Q&A with .

    Poništi
  2. 23. sij

    Biotalys announces collaboration with Chrysal to evaluate potential of biofungicide in flowers

    Poništi
  3. 22. sij

    Sofinnova Partners is pleased to announce the promotion of Michael Krel to partner. Learn more:

    Poništi
  4. proslijedio/la je Tweet

    Health care sector has $1T in investing ‘firepower’: Investor

    Poništi
  5. 21. sij

    “2020 could be the year of ,” Antoine Papiernik predicts in his recent interview with , where the pair delved into topics ranging from scientific innovation to a look forward at the potential in :

    Poništi
  6. 15. sij

    Sofinnova Partners Announces the Promotion of Michael Krel to Partner of Industrial Biotechnology Team

    Poništi
  7. 7. sij

    HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

    Poništi
  8. MedDay Reports Last Patient Study Visit in Phase 3 Clinical Trial with MD1003®*, an Important Step Towards Completion of the SPI2 Study in Progressive Multiple Sclerosis

    Poništi
  9. Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock

    Poništi
  10. TISSIUM Closes €39M Series B Funding Round

    Poništi
  11. 8. stu 2019.

    Avantium nominates Edwin Moses as Chairman of its Supervisory Board

    Poništi
  12. proslijedio/la je Tweet
    17. lis 2019.

    Sofinnova said it “will seek to invest as a founding and lead investor in start-ups and corporate spin-offs, and focus on therapeutic, paradigm-shifting technologies and products alongside visionary entrepreneurs.”:

    Poništi
  13. proslijedio/la je Tweet
    17. lis 2019.

    Sofinnova builds stacks [on stacks, on stacks] for early-stage

    Poništi
  14. proslijedio/la je Tweet
    16. lis 2019.

    French VC Sofinnova Partners will continue to invest in early stage start-ups with its €333 million ninth core fund

    Poništi
  15. Sofinnova Partners’ Antoine Papiernik joined other thought leaders to discuss France as a blueprint for European at 💡

    Poništi
  16. proslijedio/la je Tweet
    17. lis 2019.
    Poništi
  17. Pleased to announce the close of our latest early-stage venture capital fund, Sofinnova Capital IX:

    Poništi
  18. We have added a new early-stage venture capital fund to our comprehensive platform of life sciences-focused vehicles. Learn more:

    Poništi
  19. SOFINNOVA PARTNERS RAISES €333 MILLION CAPITAL IX EARLY-STAGE HEALTHCARE FUND

    Poništi
  20. ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·